Genetic suppression of ENH efficiently attenuates the migration, invasion, and proliferation of several cancer cells.[30] Additionally, ENH upregulation has been linked to tumor resistance to EGFR‐TKIs, as seen in NSCLC.[31] These results indicate that targeting ENH could be an effective anti‐tumor strategy. The gene discussed is PDLIM5; the disease is cancer.